To unlock this feature and to subscribe to our weekly evidence emails, please create a FREE orthoEvidence account.

SIGNUP

Already Have an Account?

Loading...
Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Ace Report Cover

NSAID injection of ketorolac improved UCLA scores & passive abduction in patients with SIS

Download
Share
Reprints
Cite This
About
+ Favorites
Share
Reprints
Cite This
About
+ Favorites
Ace Report Cover
August 2013

NSAID injection of ketorolac improved UCLA scores & passive abduction in patients with SIS

Vol: 2| Issue: 7| Number:70| ISSN#: 2564-2537
Study Type:Therapy
OE Level Evidence:2
Journal Level of Evidence:N/A

A double-blind randomized controlled trial comparing the effects of subacromial injection with corticosteroid versus NSAID in patients with shoulder impingement syndrome

J Shoulder Elbow Surg. 2013 May;22(5):595-601. doi: 10.1016/j.jse.2012.08.026. Epub 2012 Nov 22

Contributing Authors:
KS Min P St Pierre PM Ryan BG Marchant CJ Wilson ED Arrington

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

Synopsis

48 patients with subacromial impingement syndrome (SIS) were randomized to receive a single subacromial injection of either the nonsteroidal anti-inflammatory drug (NSAID), ketorolac, or the corticosteroid, triamcinolone, in order to determine which of the two was more effective in improving shoulder pain and function. Following assessments over a 4 week period, patients who received the NSAID inj...

CME Image

Did you know that you’re eligible to earn 0.5 CME credits for reading this report!

LEARN MORE

Join the Conversation

Please Login or Join to leave comments.

Learn about our AI Driven
High Impact Search Feature

High Impact Icon

Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.

Continue